Federated learning for predicting clinical outcomes in patients with COVID-19

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

How Venture Capitalists Are Deforming Capitalism

Biopharma Collaboration Is Key For Innovation

Gartner: 75% of VCs will use AI to make investment decisions by 2025

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Drug discovery platform Exscientia sets terms for $275 million US IPO

Major venture capital investment in European life sciences will fuel occupier market

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Innovation at the intersection of design and technology